Stoke Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. 

CEO
Ian Frederick Smith
CEOIan Frederick Smith
Employees
170
Employees170
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2014
Founded2014
Employees
170
Employees170

STOK Key Statistics

Market cap
2.02B
Market cap2.02B
Price-Earnings ratio
-11.49
Price-Earnings ratio-11.49
Dividend yield
Dividend yield
Average volume
492.93K
Average volume492.93K
High today
$33.03
High today$33.03
Low today
$31.59
Low today$31.59
Open price
$32.64
Open price$32.64
Volume
291.41K
Volume291.41K
52 Week high
$40.22
52 Week high$40.22
52 Week low
$8.70
52 Week low$8.70

Stock Snapshot

As of today, Stoke Therapeutics(STOK) shares are valued at $32.49. The company's market cap stands at 2.02B, with a P/E ratio of -11.49.

During the trading session on 2026-05-12, Stoke Therapeutics(STOK) shares reached a daily high of $33.03 and a low of $31.59. At a current price of $32.49, the stock is +2.8% higher than the low and still -1.6% under the high.

Trading volume for Stoke Therapeutics(STOK) stock has reached 291.41K, versus its average volume of 492.93K.

The stock's 52-week range extends from a low of $8.70 to a high of $40.22.

The stock's 52-week range extends from a low of $8.70 to a high of $40.22.

STOK News

Simply Wall St 3d
Did Stoke Therapeutics’ Q1 Profit-to-Loss Swing and Insider Sale Just Shift STOK’s Investment Narrative?

In the first quarter ended March 31, 2026, Stoke Therapeutics reported sales of US$6.23 million versus US$158.57 million a year earlier, shifting from net incom...

Did Stoke Therapeutics’ Q1 Profit-to-Loss Swing and Insider Sale Just Shift STOK’s Investment Narrative?

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.